microfluidic organ-on-chip drug testing market Growth Insight Report Key Developments top Competitors Analysis By FMI
NEWARK, DE | 20 Mar 2026 —The global microfluidic organ-on-chip drug testing market is entering a rapid growth phase as pharmaceutical and biotechnology companies transition from traditional animal and static cell-based assays to dynamic, human-relevant predictive models. Valued at USD 141.5 million in 2025, the market is projected to reach USD 168.0 million in 2026 and surge to USD 932.9...
0 Комментарии 0 Поделились 20 Просмотры 0 предпросмотр
Zepky https://zepky.com